Haixiang Pharmaceutical: Announcement on holding the 2024 semi-annual online results briefing
Haixiang Pharmaceutical: Semi-Annual Report Supervisory Board Resolutions Announcement
Haixiang Pharmaceutical: Company shares held by directors, supervisors and senior management and its change management system (revised in August 2024)
Haixiang Pharmaceutical: Semi-Annual Report Board Resolution Announcement
Haixiang Pharmaceutical: Special Report on the Storage and Use of Funds Raised for the Semi-Annual Year 2024
Zhejiang Hisoar Pharmaceutical: Announcement on Progress of Providing Guarantees to Subsidiaries within Consolidated Financial Statements.
Zhejiang Hisoar Pharmaceutical: Announcement regarding changes in directors and senior management personnel.
Zhejiang Hisoar Pharmaceutical: May 20, 2024 Investor Relations Activity Schedule
Zhejiang Hisoar Pharmaceutical: Progress announcement on providing guarantees for subsidiaries within the scope of the consolidated statement
Zhejiang Hisoar Pharmaceutical: April 29, 2024 Investor Relations Activity Schedule
Zhejiang Hisoar Pharmaceutical: 2023 Independent Director Debriefing Report (Qian Jianmin)
Zhejiang Hisoar Pharmaceutical: Remuneration and Assessment Committee Rules of Procedure (Revised in April 2024)
Zhejiang Hisoar Pharmaceutical: Guotai Junan Securities Co., Ltd. inspection opinions on the storage and use of funds raised by Haixiang Pharmaceutical in 2023
Zhejiang Hisoar Pharmaceutical: Shareholders' Meeting Rules of Procedure (Revised April 2024)
Zhejiang Hisoar Pharmaceutical: Internal Control Audit Report
Zhejiang Hisoar Pharmaceutical: Report on the work of the Board of Supervisors for the year 2023
Zhejiang Hisoar Pharmaceutical: Special instructions on the use of funds raised in the year
Zhejiang Hisoar Pharmaceutical: Independent Director Work System (Revised in April 2024)
Zhejiang Hisoar Pharmaceutical: Announcement on holding the 2023 online results briefing
Zhejiang Hisoar Pharmaceutical: Announcement of Board Resolutions
No Data
No Data